文献速递鼻科

过敏性鼻炎患者鼻中隔矫正术联合下鼻甲减容术的前瞻性结局研究

A Prospective Study of Outcomes of Septoplasty with Turbinate Reductions in Patients with Allergic Rhinitis.
PubMed 文献 · Otolaryngol Head Neck Surg · 2019-03-26

前瞻性观察性队列研究,纳入有症状鼻中隔偏曲伴(n=30)或不伴(n=30)过敏性鼻炎患者,行鼻中隔矫正术联合下鼻甲减容术。两组术后3个月和6个月鼻塞症状评估(NOSE)、呼吸顺畅度(EOB)及迷你鼻结膜炎生活质量问卷(mini-RQLQ)评分均显著改善并维持至6个月;过敏性鼻炎组mini-RQLQ各时间点较高,但变化幅度两组相当。

要点

  • 过敏性鼻炎组与非过敏性鼻炎组术后3个月和6个月NOSE、EOB、mini-RQLQ评分均显著改善。
  • 过敏性鼻炎组mini-RQLQ评分在所有时间点均较高,但评分变化幅度两组相当。
  • 术前设定合理预期后,过敏性鼻炎并非鼻中隔矫正术联合下鼻甲减容术的禁忌证或阻碍因素,患者可期望高度术后满意度。

核心结论

  • 过敏性鼻炎患者日常过敏相关生活质量(mini-RQLQ)受损更重,但似不削弱其因鼻塞指征接受鼻中隔矫正术联合下鼻甲减容术的获益。
  • 结构性鼻塞的症状缓解似显著改善其整体过敏相关生活质量。
  • 若术前设定合理预期,过敏性鼻炎既非鼻中隔矫正术联合下鼻甲减容术的禁忌证也非阻碍因素,这些患者可合理期望高度术后满意度。

研究设计与样本

  • 前瞻性观察性队列研究,单外科医生、大学医院。
  • 连续纳入有症状鼻中隔偏曲患者,伴过敏性鼻炎(n=30)或不伴过敏性鼻炎(n=30),入组时间2014年3月至2017年2月。
  • 所有患者接受鼻中隔矫正术和下鼻甲减容术。
  • 采用NOSE量表、mini-RQLQ和EOB Likert评分于术前及术后3个月和6个月评估,术后另加患者满意度Likert评分。

主要发现

  • 两组NOSE评分、EOB评分和mini-RQLQ评分在术后3个月和6个月均显著改善。
  • 结果从3个月维持至6个月。
  • 过敏性鼻炎组mini-RQLQ评分在所有时间点均较高,但两组评分变化幅度相当。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Examine outcomes of septoplasty with turbinate reductions in patients with allergic rhinitis as compared to patients without allergic rhinitis using validated outcome and quality-of-life (QOL) instruments. STUDY DESIGN: Prospective observational cohort study. SETTING: Single surgeon, university hospital. SUBJECTS AND METHODS: Consecutive study-eligible patients with a symptomatic nasal septal deviation, with (n = 30) or without (n = 30) documented allergic rhinitis, were enrolled from March 2014 to February 2017. All patients subsequently underwent nasal septoplasty and inferior turbinate reductions. Outcomes were studied using the Nasal Obstruction Symptom Evaluation (NOSE) scale, mini-Rhinoconjunctivitis Quality of Life Questionnaire (mini-RQLQ), and Ease-of-Breathing (EOB) Likert scores completed preoperatively and, together with a patient satisfaction Likert, at 3 and 6 months postoperatively. RESULTS: NOSE scores, EOB scores, and mini-RQLQ scores improved significantly in both groups at 3 and 6 months postoperatively. Results were sustained from 3 to 6 months. Although mini-RQLQ scores in allergic patients were higher at all intervals, the magnitude of change in scores in both groups was comparable. CONCLUSION: Although patients with allergic rhinitis report greater allergy-related QOL impairment (mini-RQLQ) on a day-to-day basis than nonallergic patients, this does not appear to attenuate the benefit they might experience from septoplasty and turbinate reductions when indicated for nasal obstruction. Furthermore, the symptomatic relief of their structural nasal obstruction appears to significantly improve their overall allergy-related quality of life. If appropriate expectations are set pre-operatively, allergic rhinitis is neither a contraindication nor a deterrent to septoplasty and turbinate reductions and these patients can reasonably expect a high degree of satisfaction post-operatively.

来源:Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Gillman GS, Staltari GV, Chang YF, et al. A Prospective Study of Outcomes of Septoplasty with Turbinate Reductions in Patients with Allergic Rhinitis. Otolaryngol Head Neck Surg. 2019. PMID: 30909804. doi:10.1177/0194599819838761

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。